Intract Pharma

Intract Pharma is a licensing and product development company specializing in oral drug delivery, offering a range of proprietary formulation technologies to deliver novel and optimized treatments tailored to patient needs. The company is a spin-off from University College London, focusing on 15 years of research and innovation from Professor Abdul Basit's laboratory. Intract’s portfolio of formulation technologies includes the use of Phloral for colon-targeted drug delivery and pre-release, as well as a multifunctional microparticulate delivery system. Additionally, Intract has developed unique gastrointestinal (GI) models that closely mimic the physiological environment of the human GI tract, enabling accurate and predictable in vitro-in vivo correlations.